The treatment of leukemia among children could be made more precise with fewer side effects with the help of more accurate methods of diagnosis. A new study led by Umeå University, Sweden, reveals that analyzing methylation ...
May 22, 2025
0
0
An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help doctors better match patients ...
May 21, 2025
0
1
A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukemia (B-ALL), the most common cancer in childhood and one that can be particularly difficult ...
May 20, 2025
0
17
Currently, half of patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia—two types of cancer that affect blood cells—do not respond adequately to treatment with CAR-T cells. The therapy involves harvesting ...
May 19, 2025
0
1
New research on children diagnosed with acute lymphoblastic leukemia (ALL) shows that the longer a patient's body mass index (BMI) falls within the overweight/obese category during treatment, the greater the risk of relapse ...
May 15, 2025
0
1
A new study has identified taurine, which is made naturally in the body and consumed through some foods, as a key regulator of myeloid cancers such as leukemia. The paper is published in Nature.
May 14, 2025
0
70
In chronic lymphocytic leukemia (CLL), certain recurrent genetic alterations are known to influence disease progression and survival. One important abnormality is the loss of part of chromosome 11, del(11q), which is associated ...
May 5, 2025
0
0
Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are the most common pediatric cancers and among the leading causes of death in children.
Apr 30, 2025
0
0
Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of human blood development, improving understanding of leukemia formation and enabling a more precise classification ...
A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia (AML) by helping doctors identify if they might relapse up to three months earlier.
Apr 28, 2025
0
0
